Capgemini – Engineering Biology, 2024

The report by the Capgemini – Engineering Biology, 2024 discusses the application of engineering biology, also known as synthetic biology, which combines principles from biology, engineering, AI, and data-driven computational techniques to create new biological systems called biosolutions. These biosolutions have sustainability advantages and can be used in various industries such as industrial production, agricultural transformation, and therapeutic purposes. The report highlights how engineering biology can modify microbes for industrial production through precision fermentation, engineer crops to improve traits like nutritional content and disease resistance, and alter human cells for medical treatments and organ creation. It emphasizes the potential of engineering biology to revolutionize multiple industries and suggests strategies for executives to adopt biosolutions. The target audience includes business executives, leaders in engineering biology startups, and government agencies/policymakers. The report aims to provide valuable insights to accelerate research, scale up operations, and support the adoption of biosolutions through regulations.